Breaking the Mould: Melanin is Key in Immune Response to Killer Fungus
News Mar 07, 2018 | Original Story by Ryan O'Hare for Imperial College London.
New research has revealed how a common fungus, which kills an estimated 200,000 people a year, triggers our immune system.
Aspergillus fumigatus is a mould commonly found in dust, compost and damp buildings, whose spores can cause lung disease and allergic reactions, and are linked with asthma.
For most healthy people, inhaling the spores does not lead to disease but for those with compromised immune systems it can be deadly.
In vulnerable patients, such as those undergoing transplantation or chemotherapy, it can lead to invasive infections that are difficult to diagnose and treat, and can be fatal in more than half of cases.
"By understanding exactly how these fungi trigger the immune system, our findings lay the groundwork for new tools to fight these difficult to treat fungal infections" commented Professor Ten Feizi, Study author.
Now findings from a study, carried out by an international group including researchers from Imperial’s Department of Medicine, have shed new light on how our immune systems respond to this deadly microorganism.
In a paper, published in the journal Nature, a group led by the MRC Centre for Medical Mycology at the University of Aberdeen, identified a new mechanism that responds to an ‘unsuspected’ part of the fungus, triggering the immune system.
Previously, scientists thought that the immune system recognised the fungi from sugars in their cell walls, but the group found that immune cells have receptors that are able to recognise a pigment in the fungi called melanin.
They also found that variants of the receptor that detects the pigment, called MelLec, make some people more susceptible to infection.
According to the researchers, the findings could help in the development of new diagnostic tools and drugs to help combat these kind of infections.
Professor Ten Feizi, Director of the Glycosciences Laboratory at Imperial College London, said: “In our Wellcome Trust-supported carbohydrate microarray facility, we analysed the immune cell receptor (MelLec) for binding to a large number of sugar structures.
"It was unpredicted to find that it binds to melanin on the fungus rather than sugars, and this is what triggers the immune cells to respond."
Dr Yan Liu, the Project Leader of the Carbohydrate Microarray Facility in the Glycosciences Laboratory at Imperial said: "High impact collaborative research such as this is typical of the activities in our Carbohydrate Microarray Facility.
“By understanding exactly how these fungi trigger the immune system, our findings lay the groundwork for new tools to fight these difficult to treat fungal infections.”
Professor Gordon Brown, from the University of Aberdeen, who led the study, said: “This is a fungus that most of us come into contact with on a daily basis without consequence. However, for vulnerable people undergoing serious medical interventions, it can be fatal.
“Understanding how our immune system responds to this invader is crucial to improving our ability to identify its presence in infected people and to develop therapies to help us treat this disease.
“This latest finding revealed that our immune system is responding to parts of the fungus we previously didn’t know it recognised. Whilst this discovery is a huge step forward it emphasises just how complex the fight against these fungi is.”
This article has been republished from materials provided by Imperial College London. Note: material may have been edited for length and content. For further information, please contact the cited source.
Stappers MHT, Clark AE, Aimanianda V, Bidula S, Reid DM, Asamaphan P, Hardison SE, Dambuza IM, Valsecchi I, Kerscher B, Plato A, Wallace CA, Yuecel R, Hebecker B, da Glória Teixeira Sousa M, Cunha C, Liu Y, Feizi T, Brakhage AA, Kwon-Chung KJ, Gow NAR, Zanda M, Piras M, Zanato C, Jaeger M, Netea MG, van de Veerdonk FL, Lacerda JF, Campos A, Carvalho A, Willment JA, Latgé JP, Brown GD. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus. Nature. 2018 Feb 28. doi: 10.1038/nature25974. [Epub ahead of print].
How Well Do Cancer Drugs Hit Their Targets? Here’s How to Find OutNews
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach.READ MORE